Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T56510 | Target Info | |||
Target Name | Apoptosis regulator Bcl-xL (BCL-xL) | ||||
Synonyms | Bcl2like protein 1; Bcl2L1; Bcl2-L-1; Bcl-XL; Bcl-2-like protein 1; BCLX; BCL2L; Apoptosis regulator Bcl-X | ||||
Target Type | Clinical trial Target | ||||
Gene Name | BCL2L1 | ||||
Biochemical Class | B-cell lymphoma Bcl-2 | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Alpha-type channels | [+] 2 Alpha-type channels | + | |||
Interacting Protein Name | Apoptosis regulator BAX (BAX) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BCL2L4 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Co-localization | [3] | |||
4 | Fluorescence Resonance Energy Transfer | [4] | |||
5 | Protein-peptide | [5] | |||
6 | Reconstituted Complex | [6] | |||
Interacting Target Name | Apoptosis regulator BAK (BAK) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CDN1; Bcl-2-like protein 7; Bcl2like protein 7; Bcl2-L-7; Bcl2L7; Bcl-2 homologous antagonist/killer; Bcl2 homologous antagonist/killer | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Fluorescence Resonance Energy Transfer | [8] | |||
3 | Protein-peptide | [5] | |||
Autophagy-related proteins | [+] 1 Autophagy-related proteins | + | |||
Interacting Target Name | Beclin-1 (BECN1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein GT197; GT197; Coiled-coil myosin-like BCL2-interacting protein; Coiledcoil myosinlike BCL2interacting protein | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [9] | |||
2 | Yeast two hybrid | [10] | |||
Auxiliary transporters | [+] 4 Auxiliary transporters | + | |||
Interacting Protein Name | Bcl2-associated agonist of cell death (BAD) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BBC2; BCL2L8 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [11] | |||
3 | Protein-peptide | [5] | |||
4 | Reconstituted Complex | [12] | |||
5 | Yeast two hybrid | [13] | |||
Interacting Protein Name | Bcl-2-like protein 11 (BCL2L11) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BAM; BIM; BOD | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [14] | |||
3 | Fluorescence Resonance Energy Transfer | [8] | |||
4 | Protein-peptide | [15] | |||
Interacting Protein Name | Bcl-2-modifying factor (BMF) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [14] | |||
2 | Protein-peptide | [15] | |||
3 | Yeast two hybrid | [16] | |||
Interacting Target Name | Apoptosis regulator Bcl-2 (BCL-2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Bcl-2; Apoptosis regulator Bcl-2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Protein-peptide | [5] | |||
Beta-barrel porins | [+] 1 Beta-barrel porins | + | |||
Interacting Target Name | Voltage-dependent anion-selective channel 1 (VDAC1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Porin 31HM; Porin 31HL; Plasmalemmal porin; Outer mitochondrial membrane protein porin 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [17] | |||
2 | Reconstituted Complex | [18] | |||
Ester hydrolases | [+] 1 Ester hydrolases | + | |||
Interacting Protein Name | Cell cycle checkpoint control protein RAD9A (RAD9A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RAD9 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [19] | |||
2 | Yeast two hybrid | [19] | |||
Kinases | [+] 1 Kinases | + | |||
Interacting Target Name | Stress-activated protein kinase JNK1 (JNK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Stress-activated protein kinase 1c; SAPK1c; SAPK1; PRKM8; Mitogen-activated protein kinase 8; MAPK 8; MAP kinase 8; JNK-46; C-Jun N-terminal kinase 1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [20] | |||
2 | Co-localization | [3] | |||
Peptidases | [+] 1 Peptidases | + | |||
Interacting Target Name | Caspase-9 (CASP9) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | MCH6; ICE-like apoptotic protease 6; ICE-LAP6; CASP-9; Apoptotic protease-activating factor 3; Apoptotic protease Mch-6; Apoptotic protease activating factor 3; APAF-3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [21] | |||
2 | Co-localization | [3] | |||
Pore-forming toxins | [+] 1 Pore-forming toxins | + | |||
Interacting Target Name | Cellular tumor antigen p53 (TP53) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tumor suppressor p53; Phosphoprotein p53; P53; Antigen NY-CO-13 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [22] | |||
2 | Reconstituted Complex | [23] | |||
3 | Yeast two hybrid | [24] | |||
Other proteins | [+] 4 Other proteins | + | |||
Interacting Protein Name | Apoptosis-stimulating of p53 protein 2 (TP53BP2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | 53BP2; ASPP2; BBP; P53BP2; PPP1R13A | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Co-crystal Structure | [25] | |||
2 | Protein-peptide | [25] | |||
3 | Yeast two hybrid | [24] | |||
Interacting Protein Name | Bcl-2-binding component 3 (BBC3) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | JFY.1; JFY1; PUMA | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [26] | |||
2 | Affinity Capture-Western | [27] | |||
3 | Protein-peptide | [15] | |||
Interacting Protein Name | Bcl-2-interacting killer (BIK) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | BIP1; BP4; NBK | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [28] | |||
2 | Protein-peptide | [29] | |||
3 | Yeast two hybrid | [16] | |||
Interacting Protein Name | Activator of apoptosis harakiri (HRK) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | DP5; HARAKIRI | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [30] | |||
2 | Fluorescence Resonance Energy Transfer | [8] | |||
3 | Protein-peptide | [15] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 2 | BAD partly reverses paclitaxel resistance in human ovarian cancer cells. Oncogene. 1998 Nov 12;17(19):2419-27. | ||||
REF 3 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. | ||||
REF 4 | BimL directly neutralizes Bcl-xL to promote Bax activation during UV-induced apoptosis. FEBS Lett. 2009 Jun 18;583(12):1873-9. | ||||
REF 5 | Development of a high-throughput fluorescence polarization assay for Bcl-x(L). Anal Biochem. 2002 Aug 1;307(1):70-5. | ||||
REF 6 | Oxidized DJ-1 interacts with the mitochondrial protein BCL-XL. J Biol Chem. 2011 Oct 7;286(40):35308-17. | ||||
REF 7 | Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005 Jun 1;19(11):1294-305. | ||||
REF 8 | High-throughput methods to detect dimerization of Bcl-2 family proteins. Anal Biochem. 2003 Nov 15;322(2):170-8. | ||||
REF 9 | Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem. 2008 Sep 12;283(37):25596-605. | ||||
REF 10 | Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol. 1998 Nov;72(11):8586-96. | ||||
REF 11 | Survival function of protein kinase C{iota} as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated bad kinase. J Biol Chem. 2005 Apr 22;280(16):16045-52. | ||||
REF 12 | BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J Biol Chem. 1997 Sep 26;272(39):24101-4. | ||||
REF 13 | Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature. 1997 Nov 27;390(6658):413-7. | ||||
REF 14 | Transforming growth factor beta-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells. Mol Cell Biol. 2005 Nov;25(22):10017-28. | ||||
REF 15 | BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell. 2005 Feb 18;17(4):525-35. | ||||
REF 16 | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. Cell. 2016 Feb 11;164(4):805-17. | ||||
REF 17 | Direct control of mitochondrial function by mTOR. Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22229-32. | ||||
REF 18 | Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells. J Biol Chem. 2005 Mar 18;280(11):10491-500. | ||||
REF 19 | Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-xL and promotes apoptosis. Nat Cell Biol. 2000 Jan;2(1):1-6. | ||||
REF 20 | Phospho-Bcl-x(L)(Ser62) plays a key role at DNA damage-induced G(2) checkpoint. Cell Cycle. 2012 Jun 1;11(11):2159-69. | ||||
REF 21 | Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4386-91. | ||||
REF 22 | Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory complex-I activity via Bcl-2 family proteins. Oncotarget. 2014 Sep 30;5(18):8452-65. | ||||
REF 23 | Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor. Genes Dev. 2010 Oct 1;24(19):2194-204. | ||||
REF 24 | A directed protein interaction network for investigating intracellular signal transduction. Sci Signal. 2011 Sep 6;4(189):rs8. | ||||
REF 25 | Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2. Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12277-82. | ||||
REF 26 | Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in -Catenin-Active Cancers. Cell Syst. 2016 Sep 28;3(3):302-316.e4. | ||||
REF 27 | Mcl-1 Degradation Is Required for Targeted Therapeutics to Eradicate Colon Cancer Cells. Cancer Res. 2017 May 1;77(9):2512-2521. | ||||
REF 28 | Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway. EMBO J. 2003 Jul 15;22(14):3580-90. | ||||
REF 29 | Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell. 2005 Feb 4;17(3):393-403. | ||||
REF 30 | The cell death-promoting gene DP5, which interacts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein. J Biol Chem. 1999 Mar 19;274(12):7975-81. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.